STAAR Surgical Company (STAA) Financials

STAA Assets vs Liabilities

DateAssetsLiabilities
2024-01-31 488.7 million 102.7 million
2023-10-31 471.5 million 92.9 million
2023-07-31 440.7 million 87.0 million
2023-04-30 418.9 million 80.0 million

STAA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-01-31 28.9 million 182000
2023-10-31 -15.2 million 8.8 million
2023-07-31 -9.3 million 8.4 million
2023-04-30 -8.0 million 6.1 million

STAA Net Income

No data available :(

STAA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-01-31 220.7 million - -
2023-10-31 188.1 million - 35.8 million
2023-07-31 192.0 million - 35.9 million
2023-04-30 203.8 million - 32.5 million

STAA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-01-31 49.2 million
2023-10-31 49.4 million
2023-07-31 49.5 million
2023-04-30 49.5 million

STAA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-01-31 3.1 million 10.9 million 16.9 million 22.6 million
2023-10-31 9.2 million 11.5 million 19.3 million 26.6 million
2023-07-31 3.0 million 11.8 million 18.1 million 32.3 million
2023-04-30 2.9 million 10.3 million 18.1 million 26.4 million

STAA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-01-31 76.3 million 15.5 million
2023-10-31 80.3 million 16.7 million
2023-07-31 92.3 million 21.6 million
2023-04-30 73.5 million 16.0 million

STAA

Price: $45.51

52 week price:
26.66
68.27

Earnings Per Share: 0.43 USD

P/E Ratio: 81.18

Exchange: NGM

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 638969

Ebitda: 1.9 million

Market Capitalization: 2.2 billion

Links: